ScienceDex / Researcher record
Patel, Milan
- Pathogendx (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $8,919,208 | 1 | #290 |
| 2022 | $590,553 | 1 | #19,725 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY2022 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Patel, Milan as a PI. Multi-PI records show the full award amount for context.
- 75N92021C00001-P00004-9999-1N02Contact PITO UPDATE THE PERFORMANCE WORK STATEMENT FOR RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TE$590.6Kaward amount
Award organization
Organizations that administered FY2022 awards listing Patel, Milan as a PI.
FY2022 award administered by Pathogendx ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardPathogendx
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #290
- 2021Entered Top 25% NationallyRanked #290
- 2021Entered Top 10% NationallyRanked #290
- 2021Entered Top 5% NationallyRanked #290